Biotech China 2014

Biotechnology: Genentech

Total Score People Score Events Score
31 31 11
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Expanding the Druggable Genome Chairperson: Stephen W. Fesik, Vanderbilt University School of Medicine, Nashville, TN Domagoj Vucic
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Peter K Jackson
February 10, 2013 7thANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE: An Intensive Course on Translating Research into Drugs Antibodies and Immunotherapy for Neurodegeneration Ryan J. Watts
October 6, 2009 Phage Display to Develop Therapeutic Antibodies Synthetic PDZ Domains for Functional Genomics Sachdev Sidhu
Antibody Fragments and Scaffolds Sachdev Sidhu
August 26, 2009 Optimizing Mammalian Cell Lines Development of a Novel Double Selection System to Improve Antibody Productivity in CHO Cell Lines Domingos Ng
June 23, 2009 Viral Safety for BioLogics Detergent Inactivation as a robust viral clearance step Bin Yang
Morning coffee David P. Davis
Alternative Virus Validation Filtration Strategy Using Bacteriophage as a Model Virus Rachel Specht
June 16, 2009 7th Annual Comparability for Biologics Selection of acceptance criteria for comparability studies throughout the development lifecycle Wassim Nashabeh
Regulatory expectations in the US for demonstrating comparability of biotechnology products Earl Dye
March 17, 2009 Bio Medical Asia 2009 Opening keynote: Leadership, innovation and efficiency: Key success factors of biomanufacturing Patrick , Yang
Managing the bottleneck in downstream processing: Matching the manufacturing capacity with upstream yield Brian Kelley
The Biotech Manufacturing World is Flat Patrick , Yang
November 11, 2008 3rd Annual European Post- Translational Modifications Improving the chemical stability of a therapeutic monoclonal antibody for aspartate isomerisation Jun Liu
Environmental effects on product quality: approaches to understanding and controlling glycosylation of recombinant proteins Martin Gawlitzek
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Analysis of Protein Glycosylation (10:45-13:25) An Song
Analysis of Protein Glycosylation:Anticipating Effects of Glycosylation on Effector Functions (10:45-11:15) An Song
Causes and Assessment of Product and Process-Related Impurities (13:25-18:30) Fred Jacobson
Causes and Assessment of Product and Process-Related Impurities:Protein Aggregation and Bioprocessing (13:30-14:00) Fred Jacobson
Early Formulation Development (08:15-09:15) Jim Andya
Early Formulation Development: Early Development Screening of Monoclonal Antibody Formulations (08:15-08:45) Jim Andya
Process and Analytical Related Issues (15:30-17:00) Ron Taticek
Process and Analytical Related Issues: Quality by Design in the Development of Post-Approval Changes for Cell Culture Processes (15:30-16:00) Ron Taticek
October 3, 2007 MAOS 2007 Microwave Assisted Organic Synthesis Congress Microwave-Assisted Proteomics in the Biotechnology Area Wendy Sandoval
September 30, 2007 BioProcess International Conference & Exhibition Scaling Up from Bench through Commercialization , Best Practices for Strategic Scale Up Decisions (07:00 - 12:15) David H. Reifsnyder
Best Practices for Strategic Scale Up Decisions: Evolution of a Process Development Strategy David H. Reifsnyder
Production & Economics of Biopharmaceuticals : Enhancing Operational Excellence and Process Efficiencies (13:45 - 15:30) Mark Skoog
Enhancing Operational Excellence and Process Efficiencies : Fermentation Operational Excellence Mark Skoog
Scaling Up from Bench through Commercialization ; Regulatory and Quality Considerations (13:45 - 17:45) Mary B. Sliwkowski, Markus Gemuend
Regulatory and Quality Considerations : A Biopharmaceutical Industry Perspective on Quality By Design Mary B. Sliwkowski
Regulatory and Quality Considerations : KEYNOTE PRESENTATION; Genentech's Manufacturing Strategy and Vision of Future Needs Markus Gemuend
Scaling Up from Bench through Commercialization ; Scale Down Models, Process Characterization and Validation (08:00 - 12:00) Srikanth R. Chary
Scale Down Models, Process Characterization and Validation : Predictive Scale-Down Models for Cell Culture: Avoiding Pitfalls and Establishing Model Comparability Srikanth R. Chary
Early Stage Process Development - Getting to Clinic Faster (8:15 - 11:30) Amy Shen
Early Stage Process Development - Getting to Clinic Faster : Therapeutic Antibody Production Cell Line Development with an Improved Selection Process and Accelerated Timeline Amy Shen
Cell Culture & Upstream Processing (13:45 - 18:00) David Chang
Cell Culture & Upstream Processing : Evaluation and Impact of Hydrolysates on Production Yield Improvement David Chang
Overcoming the Challenges of the Ton Scale Process : Purification Process Development to Increase Capacity in an Existing Manufacturing Facility Christopher Teske
Recovery & Purification ; Overcoming the Challenges of the Ton Scale Process (13:45 - 16:00) Christopher Teske
Cell Culture & Upstream Processing: Chairperson's Remarks Suzanne Kuo
Commercial Process Readiness, Troubleshooting and Improvements (13:45 - 17:00) Marion Piquet, Eric Fallon
Commercial Process Readiness, Troubleshooting and Improvements : Data Mining with AvastinĀ® for Process Improvements and Optimization Eric Fallon
Commercial Process Readiness, Troubleshooting and Improvements : Efficient Cell Culture Characterization and Validation Studies Using a Scale-down Model for Changes to a Licensed Antibody Process Marion Piquet
Recovery & Purification: Chairperson's Remarks Chris Dowd
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.